跳至主要内容
临床试验/NCT03470467
NCT03470467招募中不适用

Posterior Reversible Encephalopathy Syndrome in the Critically Ill Patients

Ictal Group1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2018年3月9日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Ictal Group
入组人数
300
试验地点
1
主要终点
Favorable outcome

研究概览

简要总结

Posterior Reversible Encephalopathy Syndrome prospective (PRES) registry. Data collection using a standardized form : demographic data and data related to the PRES, including circumstances of onset, dates and times of onset and of symptoms control, on-scene clinical findings, clinical and radiological features of PRES, pre-hospital and hospital care providers, timing of antiepileptic, antihypertensive drugs and supportive treatments, results of etiological investigations, cause of PRES, type and dosage of antiepileptic and antihypertensive drugs. Dates and times of EEG monitoring, EEG results, radiological and biological investigations. Outcomes including vital status and Glasgow Outcome Scale score at ICU and hospital discharge, day-90 and 1-year after SE and determined based on data in the ICU and/or neurologist charts and/or patients phone interview

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age >= 18 years
  • Posterior Reversible Encephalopathy Syndrome defined as:
  • combination of consciousness impairment, seizure activity, headaches, visual abnormalities, nausea/vomiting, and focal neurological signs AND
  • cerebral imaging abnormalities involving the white matter (brain CT scan hypodensities AND/OR Brain MRI hypoT1, hyper T2 FLAIR)
  • intensive care unit admission

排除标准

  • normal cerebral imaging

结局指标

主要结局

Favorable outcome

时间窗: 1 year

A favorable outcome is defined by a Glasgow Outcome Scale (GOS) of 5. The Glasgow Outcome Scale (GOS) will be determined during a structured interview conducted by an independent assessor. The GOS score : \[1: Death, 2: Persistent vegetative state, 3: Severe disability, 4: Moderate disability, 5 : Low disability\]

次要结局

  • Functional impairment(3-months and 1-year, 5-years, 10-years)
  • Recurrent PRES(3-months and 1-year, 5-years, 10-years)
  • Favorable outcome(3-months and 5-years, 10-years)
  • Low or moderate disability(3-months and 1-year, 5-years, 10-years)
  • Mortality rate(ICU, hospital discharge, 3-months and 1-year, 5-years, 10-years)

研究者

发起方
Ictal Group
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验